Bioscience Animal (Thailand) Performance
| BIS Stock | 3.28 0.04 1.23% |
The firm shows a Beta (market volatility) of 0.0345, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bioscience Animal's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bioscience Animal is expected to be smaller as well. At this point, Bioscience Animal Health has a negative expected return of -0.11%. Please make sure to confirm Bioscience Animal's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Bioscience Animal Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bioscience Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
| Payout Ratio | 0.6961 |
Bioscience |
Bioscience Animal Relative Risk vs. Return Landscape
If you would invest 356.00 in Bioscience Animal Health on September 12, 2024 and sell it today you would lose (28.00) from holding Bioscience Animal Health or give up 7.87% of portfolio value over 90 days. Bioscience Animal Health is producing return of less than zero assuming 2.1429% volatility of returns over the 90 days investment horizon. Simply put, 19% of all stocks have less volatile historical return distribution than Bioscience Animal, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bioscience Animal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioscience Animal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bioscience Animal Health, and traders can use it to determine the average amount a Bioscience Animal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0522
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIS |
Estimated Market Risk
| 2.14 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bioscience Animal is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioscience Animal by adding Bioscience Animal to a well-diversified portfolio.
Bioscience Animal Fundamentals Growth
Bioscience Stock prices reflect investors' perceptions of the future prospects and financial health of Bioscience Animal, and Bioscience Animal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioscience Stock performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0444 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 2.37 B | |||
| Shares Outstanding | 314 M | |||
| Price To Book | 3.40 X | |||
| Price To Sales | 1.13 X | |||
| Revenue | 2.2 B | |||
| EBITDA | 80.95 M | |||
| Book Value Per Share | 2.38 X | |||
| Earnings Per Share | 0.20 X | |||
About Bioscience Animal Performance
By examining Bioscience Animal's fundamental ratios, stakeholders can obtain critical insights into Bioscience Animal's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Bioscience Animal is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Bioscience Animal Health performance evaluation
Checking the ongoing alerts about Bioscience Animal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioscience Animal Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioscience Animal generated a negative expected return over the last 90 days | |
| About 84.0% of the company shares are held by company insiders |
- Analyzing Bioscience Animal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioscience Animal's stock is overvalued or undervalued compared to its peers.
- Examining Bioscience Animal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioscience Animal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioscience Animal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioscience Animal's stock. These opinions can provide insight into Bioscience Animal's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Bioscience Stock
Bioscience Animal financial ratios help investors to determine whether Bioscience Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioscience with respect to the benefits of owning Bioscience Animal security.